BioCentury
ARTICLE | Deals

Asia’s innovation moment expands beyond China

An analysis of dealmaking in 2024-25 shows Asia biotechs, ex-China, leaning into enabling technologies and first-in-class bets

March 18, 2026 10:32 PM UTC

As China establishes its biotech footprint on the global stage, other regions in Asia are growing their presence, with investments, increasing sophistication and a rising crop of talent — both home-grown and with experience from global MNCs.

Their challenge is to learn from the China model, while finding ways to differentiate and become a valuable destination for investors and partners. ...